Safingol

From WikiMD.org
Jump to navigation Jump to search

Safingol (pronunciation: /ˈsæfɪŋɡɒl/) is a lipid-based drug that is currently under investigation for its potential use in the treatment of cancer. It is a synthetic derivative of sphingosine, a naturally occurring amino alcohol that plays a crucial role in cell signaling and apoptosis.

Etymology

The term "Safingol" is derived from the words "safe" and "sphingolipid". The prefix "safe" is used to indicate the drug's potential safety profile, while "sphingolipid" refers to the class of lipids from which Safingol is derived.

Pharmacology

Safingol acts by inhibiting protein kinase C, an enzyme that plays a key role in cell cycle regulation and signal transduction. By inhibiting this enzyme, Safingol can potentially halt the growth of cancer cells and induce apoptosis.

Clinical Trials

Safingol has been tested in several clinical trials for its potential use in treating various types of cancer, including breast cancer, lung cancer, and pancreatic cancer. The results of these trials have been promising, but further research is needed to fully understand the drug's efficacy and safety profile.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski